SREBF1 and Hepatic steatosis: As expected, treatment of reproterol significantly attenuated oleic acid-induced LD biogenesis and HFD-induced hepatic steatosis likely via increasing ATGL-mediated lipolysis and decreasing SREBP1c transcriptional activity.